175 related articles for article (PubMed ID: 11282238)
1. Screening effect of PEG on avidin binding to liposome surface receptors.
Kaasgaard T; Mouritsen OG; Jørgensen K
Int J Pharm; 2001 Feb; 214(1-2):63-5. PubMed ID: 11282238
[TBL] [Abstract][Full Text] [Related]
2. Receptor mediated binding of avidin to polymer covered liposomes.
Kaasgaard T; Mouritsen OG; Jørgensen K
J Liposome Res; 2001; 11(1):31-42. PubMed ID: 19530917
[TBL] [Abstract][Full Text] [Related]
3. Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes.
Li WM; Xue L; Mayer LD; Bally MB
Biochim Biophys Acta; 2001 Aug; 1513(2):193-206. PubMed ID: 11470091
[TBL] [Abstract][Full Text] [Related]
4. Poly(ethylene glycol)-modified phospholipids prevent aggregation during covalent conjugation of proteins to liposomes.
Harasym TO; Tardi P; Longman SA; Ansell SM; Bally MB; Cullis PR; Choi LS
Bioconjug Chem; 1995; 6(2):187-94. PubMed ID: 7599262
[TBL] [Abstract][Full Text] [Related]
5. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
6. Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization.
Biswas S; Dodwadkar NS; Sawant RR; Torchilin VP
Bioconjug Chem; 2011 Oct; 22(10):2005-13. PubMed ID: 21870873
[TBL] [Abstract][Full Text] [Related]
7. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
Dos Santos N; Allen C; Doppen AM; Anantha M; Cox KA; Gallagher RC; Karlsson G; Edwards K; Kenner G; Samuels L; Webb MS; Bally MB
Biochim Biophys Acta; 2007 Jun; 1768(6):1367-77. PubMed ID: 17400180
[TBL] [Abstract][Full Text] [Related]
8. Poly(ethylene glycol)-induced and temperature-dependent phase separation in fluid binary phospholipid membranes.
Lehtonen JY; Kinnunen PK
Biophys J; 1995 Feb; 68(2):525-35. PubMed ID: 7696506
[TBL] [Abstract][Full Text] [Related]
9. Prevention of antibody-mediated elimination of ligand-targeted liposomes by using poly(ethylene glycol)-modified lipids.
Li WM; Mayer LD; Bally MB
J Pharmacol Exp Ther; 2002 Mar; 300(3):976-83. PubMed ID: 11861806
[TBL] [Abstract][Full Text] [Related]
10. p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups.
Torchilin VP; Levchenko TS; Lukyanov AN; Khaw BA; Klibanov AL; Rammohan R; Samokhin GP; Whiteman KR
Biochim Biophys Acta; 2001 Apr; 1511(2):397-411. PubMed ID: 11286983
[TBL] [Abstract][Full Text] [Related]
11. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target.
Klibanov AL; Maruyama K; Beckerleg AM; Torchilin VP; Huang L
Biochim Biophys Acta; 1991 Feb; 1062(2):142-8. PubMed ID: 2004104
[TBL] [Abstract][Full Text] [Related]
12. Biotin-fluorophore conjugates with poly(ethylene glycol) spacers retain intense fluorescence after binding to avidin and streptavidin.
Gruber HJ; Marek M; Schindler H; Kaiser K
Bioconjug Chem; 1997; 8(4):552-9. PubMed ID: 9258455
[TBL] [Abstract][Full Text] [Related]
13. Effects of phosphatidylserine on membrane incorporation and surface protection properties of exchangeable poly(ethylene glycol)-conjugated lipids.
Chiu GN; Bally MB; Mayer LD
Biochim Biophys Acta; 2002 Feb; 1560(1-2):37-50. PubMed ID: 11958774
[TBL] [Abstract][Full Text] [Related]
14. "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.
Sawant RM; Hurley JP; Salmaso S; Kale A; Tolcheva E; Levchenko TS; Torchilin VP
Bioconjug Chem; 2006; 17(4):943-9. PubMed ID: 16848401
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids.
Bradley AJ; Devine DV; Ansell SM; Janzen J; Brooks DE
Arch Biochem Biophys; 1998 Sep; 357(2):185-94. PubMed ID: 9735159
[TBL] [Abstract][Full Text] [Related]
16. Effects of various spacers between biotin and the phospholipid headgroup on immobilization and sedimentation of biotinylated phospholipid-containing liposomes facilitated by avidin-biotin interactions.
Sakamoto Y; Kikuchi K; Umeda K; Nakanishi H
J Biochem; 2017 Sep; 162(3):221-226. PubMed ID: 28444248
[TBL] [Abstract][Full Text] [Related]
17. Avidin-biotin-PEG-CPA complexes as potential EPR-directed therapeutic protein carriers: preparation and characterization.
Ke S; Wright JC; Kwon GS
Bioconjug Chem; 2007; 18(5):1644-50. PubMed ID: 17705554
[TBL] [Abstract][Full Text] [Related]
18. Improved imaging of infections by avidin-induced clearance of 99mTc-biotin-PEG liposomes.
Laverman P; Zalipsky S; Oyen WJ; Dams ET; Storm G; Mullah N; Corstens FH; Boerman OC
J Nucl Med; 2000 May; 41(5):912-8. PubMed ID: 10809208
[TBL] [Abstract][Full Text] [Related]
19. Basic studies on heterobifunctional biotin-PEG conjugates with a 3-(4-pyridyldithio)propionyl marker on the second terminus.
Kaiser K; Marek M; Haselgrübler T; Schindler H; Gruber HJ
Bioconjug Chem; 1997; 8(4):545-51. PubMed ID: 9258454
[TBL] [Abstract][Full Text] [Related]
20. Drug delivery by phospholipase A(2) degradable liposomes.
Davidsen J; Vermehren C; Frokjaer S; Mouritsen OG; Jørgensen K
Int J Pharm; 2001 Feb; 214(1-2):67-9. PubMed ID: 11282239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
